Supports
Online Inquiry
Liposomes' low resilience to stomach pH, enzymatic breakdown, and poor stability all restrict their application. To change the surface properties of liposomes, a variety of synthetic and natural polymers were used. Chitosan (CS) is the most common biopolymer utilized to modify liposomes. Creative Biolabs provides chitosan-based liposome development services, to provide high-quality and efficient solutions to fulfill your unique drug delivery requirements.
Chitosan (CS) is a naturally cationic polymer with excellent physicochemical and biological properties, such as biodegradability, antimicrobial activity, biocompatibility, low toxicity, blood compatibility, and adhesiveness. The positively charged amino groups of chitosan interact electrostatically with negatively charged liposomes, and hydrogen bonds form between the hydroxyl groups of chitosan and the liposomes, resulting in a chitosan coating on the liposome surface. These chitosan-coated liposomes, also known as chitosomes, regulate the biological functions of liposomal vesicles by delaying drug release, enhancing liposome stability, half-life, and bioavailability. However, the solubility of chitosan in acidic media and its insolubility in neutral or alkaline media significantly limit its applications. To retain the biological properties of chitosan while extending its solubility across a wide pH range, various derivatives can be synthesized by grafting hydroxyl or amino functional groups.
Chitosan derivatives are compounds that have undergone chemical modification of chitosan's amino and hydroxyl groups by introducing new functional groups, allowing for the improvement of their solubility, biocompatibility, and functional properties without altering their inherent characteristics. The main chitosan derivatives used for modifying liposomes include glycol chitosan, N-dodecyl chitosan, N-trimethyl chitosan, and thioglycolic acid chitosan, among others.
Chitosan Derivatives | Chemical Structure | Aim of Chitosan Derivatization |
Chitosan |
|
|
Glycol chitosan |
|
|
Methylated N-(4-N,N-dimethylaminobenzyl) chitosan (TMBz-chitosan) |
|
|
N-dodecyl chitosan |
|
|
N-[(2-hydroxy-3-trimethylamine) propyl] chitosan chloride (HPTMA-chitosan) |
|
|
N-dodecyl-chitosan N-[(2-hydroxy-3-trimethylamine) propyl]chloride (N-dodecyl-chitosan-HPTMA) |
|
|
N-trimethyl chitosan |
|
|
PEGylated octadecyl-quaternized lysine modified chitosan |
|
|
Pelargonic chitosan (n=7) Lauric chitosan (n=10) |
|
|
Thioglycolic acid chitosan (TGA-chitosan) |
|
|
Thioglycolic acid 6-mercaptonicotinamide-conjugate chitosan (TGA-MNA-chitosan) |
|
As an industry-leading supplier, Creative Biolabs possesses extensive experience in the development of chitosomes, aiming to revolutionize drug delivery with their unique properties. Contact us to explore how our expertise in chitosomes and other chitosan-based delivery systems can be customized to your needs and contribute to a healthier future.
References